In the early 1990s, a subset of the health sector— patented drugs—burst quite unexpectedly into the international trade debate. The ongoing trade negotiations of the Uruguay Round were in disarray, and support from sectors that relied on the protection of intellectual property rights became essential to move them forward.1 Indeed, the Uruguay Round Agreement was signed in 1994 only because it included a then much praised Trade-Related Intellectual Property Rights (TRIPs) agreement.

Attachments:
Download this file (092_PUBLIC_LANCET_26_March_2005_The_Lancet_Trade_drugs_and_health.pdf)Trade, drugs, and health-care services[Millennium Project]45 kB

The Millennium Development Goals have become an international standard against which to assess trends in development and human well being. Their adoption in 2000 coincided with two important factors: the growing recognition of the role of science and technology in solving human problems, and the emergence of new infectious diseases. These developments have helped to define biomedical research as one of the most critical public policy issues facing the global community. The state of human health in much of the developing world continues to decline at a time when the world’s fund of biomedical knowledge continues to expand. This challenge offers new opportunities for promoting international cooperation in biomedical research of relevance to developing countries as outlined in the report of the Millennium Project Task Force on Science, Technology and Innovation.1 Addressing health challenges of the developing world will require new forms of international partnerships that take into account emerging opportunities in the globalisation of scientific knowledge.

Página 2 de 2

Sobre a REDE-TB

A Rede Brasileira de Pesquisa em Tuberculose (REDE-TB) é uma Organização Não Governamental (ONG) de direito privado sem fins lucrativos, preocupada em auxiliar no desenvolvimento não só de novos medicamentos, novas vacinas, novos testes diagnósticos e novas estratégias de controle de TB, mas também na validação dessas inovações tecnológicas, antes de sua comercialização no país e/ou de sua implementação nos Programa de Controle de TB no País.


bt2

Contato

E-mail: redetb.rp@gmail.com

Tel: +55 (21)3938 - 2426
Tel/ Fax: +55 (21)3938 - 2431.

Endereço: Avenida Carlos Chagas Filho, 791, Cidade Universitária - Ilha do Fundão, Rio de Janeiro, RJ - Brasil. CEP: 21941-904

Assine a newsletter da REDE-TB

Curta REDE-TB no Facebook